[Cardiac amyloidosis : simplifying the diagnosis of a complex disease]

Nicolas Dayer1, Pierre Monney1, Sarah Hugelshofer1

  • 1Service de cardiologie, Centre hospitalier universitaire vaudois, 1011 Lausanne.

PubMed

Insights

Amyloidosis, a protein misfolding disease, often impacts the heart, leading to heart failure. Early diagnosis and new treatments are crucial for improving outcomes in this serious condition.

Area of Science:

  • Cardiology
  • Nephrology
  • Neurology

Background:

  • Amyloidosis is a systemic disease caused by misfolded protein deposition.
  • Cardiac involvement is common and leads to severe heart failure.
  • Light-chain and transthyretin amyloidosis are the most prevalent types.

Purpose of the Study:

  • To highlight the importance of prompt diagnosis in amyloidosis.
  • To emphasize the need for multidisciplinary approaches in patient management.
  • To underscore the impact of recent advancements in disease-modifying treatments.

Main Methods:

  • Review of current literature on amyloidosis diagnosis and treatment.
  • Analysis of clinical presentation and prognostic factors.
  • Discussion of diagnostic criteria and imaging modalities.

Main Results:

  • Amyloidosis significantly impacts cardiac function, often progressing to heart failure.
  • Timely diagnosis is critical due to the availability of effective treatments.
  • Multidisciplinary care improves patient outcomes.

Conclusions:

  • Early recognition of amyloidosis signs is essential.
  • Advancements in disease-modifying therapies have improved prognosis.
  • A coordinated, multidisciplinary approach is vital for managing amyloidosis effectively.